Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2015 by George Robinson and Ross Hyett, Oxford Investment Consultants (OIC) is based in Oxford, UK. The firm specializes in early-stage investments, particularly in technology and biotech companies emerging from Oxford University and other prominent UK research institutions.
OIC invests in companies from Seed through Series C funding rounds, emphasizing those that tackle significant global challenges in biotechnology, healthcare, and technology. Their strategy targets transformative companies that can make a substantial impact in their respective fields.
Notable portfolio companies include Biofidelity, specializing in liquid biopsy for cancer diagnosis; Caristo Diagnostics, which develops software for early heart disease diagnosis; OrganOx, focused on extending organ life prior to transplant; Oxford PV, working on next-generation photovoltaic technology; and SpyBiotech, a clinical-stage vaccine platform company.
Email your pitch deck to applications@oxfordinvestmentconsultants.com for consideration.
OIC often leads funding rounds, particularly in early-stage investments where they can provide significant support and guidance.
OIC is open to follow-on investments, especially for companies that demonstrate strong growth and alignment with their investment thesis.
Specific details about the fund size are not publicly disclosed, but OIC focuses on substantial investments across multiple funding stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.